Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Stambuk

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Postgraduate Medical Journal|January 1, 1986
Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary studyM Y Morgan, D Stambuk
The Journal of Infection|January 1, 1989
Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experienceD Stambuk, D Hawkins, B G Gazzard
Journal of Hepatology|April 1, 1987
Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over studyM Y Morgan, K E Hawley, D Stambuk
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 1, 1987
Reductions in breath ethanol readings in normal male volunteers following mouth rinsing with water at differing temperaturesP M Gaylarde, D Stambuk, M Y Morgan
Alimentary Pharmacology & Therapeutics|April 1, 1990
Amino acid tolerance in cirrhotic patients following oral protein and amino acid loadsM Y Morgan, K E Hawley, D Stambuk
Alimentary Pharmacology & Therapeutics|February 1, 1990
Pharmacokinetics of famotidine in normal subjects and in patients with chronic liver diseaseM Y Morgan, D Stambuk, J Cottrell, et al.
Journal of Medical Systems|September 14, 2000
Information subsystem of the difference between anions sum and hardness of water and its influence on human healthN Stambuk-Giljanović, B Matoković, D Stambuk, et al.
British Journal of Clinical Pharmacology|February 1, 1989
The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver diseaseN R Scott, D Stambuk, J Chakraborty, et al.
Clinical Science (London, England : 1979)|April 1, 1988
Caffeine clearance and biotransformation in patients with chronic liver diseaseN R Scott, D Stambuk, J Chakraborty, et al.
Advances in Alcohol & Substance Abuse|January 1, 1988
The measurement of D,L-2,3-butanediol in controls and patients with alcoholic cirrhosisJ P Casazza, J Freitas, D Stambuk, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Postgraduate Medical Journal|January 1, 1986
Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary studyM Y Morgan, D Stambuk
The Journal of Infection|January 1, 1989
Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experienceD Stambuk, D Hawkins, B G Gazzard
Journal of Hepatology|April 1, 1987
Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over studyM Y Morgan, K E Hawley, D Stambuk
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 1, 1987
Reductions in breath ethanol readings in normal male volunteers following mouth rinsing with water at differing temperaturesP M Gaylarde, D Stambuk, M Y Morgan
Alimentary Pharmacology & Therapeutics|April 1, 1990
Amino acid tolerance in cirrhotic patients following oral protein and amino acid loadsM Y Morgan, K E Hawley, D Stambuk
Alimentary Pharmacology & Therapeutics|February 1, 1990
Pharmacokinetics of famotidine in normal subjects and in patients with chronic liver diseaseM Y Morgan, D Stambuk, J Cottrell, et al.
Journal of Medical Systems|September 14, 2000
Information subsystem of the difference between anions sum and hardness of water and its influence on human healthN Stambuk-Giljanović, B Matoković, D Stambuk, et al.
British Journal of Clinical Pharmacology|February 1, 1989
The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver diseaseN R Scott, D Stambuk, J Chakraborty, et al.
Clinical Science (London, England : 1979)|April 1, 1988
Caffeine clearance and biotransformation in patients with chronic liver diseaseN R Scott, D Stambuk, J Chakraborty, et al.
Advances in Alcohol & Substance Abuse|January 1, 1988
The measurement of D,L-2,3-butanediol in controls and patients with alcoholic cirrhosisJ P Casazza, J Freitas, D Stambuk, et al.
Pageof 2